Literature DB >> 29987151

Prevalence and Molecular Characterization of Escherichia coli Clinical Isolates Carrying mcr-1 in a Chinese Teaching Hospital from 2002 to 2016.

Hong Lu1, Chong Wang1, Guofeng Dong2, Chunquan Xu1, Xiaoxiao Zhang1, Haiyang Liu1, Majun Zhang1, Jianming Cao3, Tieli Zhou4.   

Abstract

Entities:  

Keywords:  Escherichia coli; clinical isolates; colistin; mcr-1; prevalence; resistance

Mesh：

Substances：

Year:  2018        PMID： 29987151      PMCID： PMC6125521          DOI： 10.1128/AAC.02623-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  7 in total

1.  Silent dissemination of colistin-resistant Escherichia coli in South America could contribute to the global spread of the mcr-1 gene.

Authors:  Miriam R Fernandes; Quezia Moura; Luciana Sartori; Ketrin C Silva; Marcos Pv Cunha; Fernanda Esposito; Ralf Lopes; Luciana K Otutumi; Daniela D Gonçalves; Milena Dropa; Maria H Matté; Daniel Fm Monte; Mariza Landgraf; Gabriela R Francisco; Maria Fc Bueno; Doroti de Oliveira Garcia; Terezinha Knöbl; Andrea M Moreno; Nilton Lincopan
Journal:  Euro Surveill       Date:  2016-04-28

2.  Coproduction of MCR-1 and NDM-1 by Colistin-Resistant Escherichia coli Isolated from a Healthy Individual.

Authors:  Lan-Lan Zhong; Yan-Fen Zhang; Yohei Doi; Xi Huang; Xue-Fei Zhang; Kun-Jiao Zeng; Cong Shen; Sandip Patil; Yong Xing; Yutian Zou; Guo-Bao Tian
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

3.  Prevalence of mcr-1 in Escherichia coli and Klebsiella pneumoniae recovered from bloodstream infections in China: a multicentre longitudinal study.

Authors:  Jingjing Quan; Xi Li; Yan Chen; Yan Jiang; Zhihui Zhou; Huichuan Zhang; Lu Sun; Zhi Ruan; Ye Feng; Murat Akova; Yunsong Yu
Journal:  Lancet Infect Dis       Date:  2017-01-28       Impact factor: 25.071

4.  Prevalence, risk factors, outcomes, and molecular epidemiology of mcr-1-positive Enterobacteriaceae in patients and healthy adults from China: an epidemiological and clinical study.

Authors:  Yang Wang; Guo-Bao Tian; Rong Zhang; Yingbo Shen; Jonathan M Tyrrell; Xi Huang; Hongwei Zhou; Lei Lei; Hong-Yu Li; Yohei Doi; Ying Fang; Hongwei Ren; Lan-Lan Zhong; Zhangqi Shen; Kun-Jiao Zeng; Shaolin Wang; Jian-Hua Liu; Congming Wu; Timothy R Walsh; Jianzhong Shen
Journal:  Lancet Infect Dis       Date:  2017-01-28       Impact factor: 25.071

5.  Genomic and Molecular Characterization of Clinical Isolates of Enterobacteriaceae Harboring mcr-1 in Colombia, 2002 to 2016.

Authors:  Sandra Yamile Saavedra; Lorena Diaz; Magdalena Wiesner; Adriana Correa; Stefany Alejandra Arévalo; Jinnethe Reyes; Andrea Melissa Hidalgo; Elsa de la Cadena; Marcela Perenguez; Lucy Angeline Montaño; Javier Ardila; Rafael Ríos; María Victoria Ovalle; Paula Díaz; Paola Porras; Maria V Villegas; Cesar A Arias; Mauricio Beltrán; Carolina Duarte
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

6.  Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study.

Authors:  Yi-Yun Liu; Yang Wang; Timothy R Walsh; Ling-Xian Yi; Rong Zhang; James Spencer; Yohei Doi; Guobao Tian; Baolei Dong; Xianhui Huang; Lin-Feng Yu; Danxia Gu; Hongwei Ren; Xiaojie Chen; Luchao Lv; Dandan He; Hongwei Zhou; Zisen Liang; Jian-Hua Liu; Jianzhong Shen
Journal:  Lancet Infect Dis       Date:  2015-11-19       Impact factor: 25.071

7.  Detection of the mcr-1 Colistin Resistance Gene in Carbapenem-Resistant Enterobacteriaceae from Different Hospitals in China.

Authors:  Hua Yu; Fen Qu; Bin Shan; Bin Huang; Wei Jia; Cha Chen; Aiqing Li; Minhui Miao; Xin Zhang; Chunmei Bao; Yunmin Xu; Kalyan D Chavda; Yi-Wei Tang; Barry N Kreiswirth; Hong Du; Liang Chen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191
  7 in total
  6 in total

1.  Colistin Resistance and Molecular Characterization of the Genomes of mcr-1-Positive Escherichia coli Clinical Isolates.

Authors:  Qiaoling Li; Changrui Qian; Xueya Zhang; Tingting Zhu; Weina Shi; Mengdi Gao; Chunlin Feng; Ming Xu; Hailong Lin; Li Lin; Junwan Lu; Xi Lin; Kewei Li; Teng Xu; Qiyu Bao; Changchong Li; Hailin Zhang
Journal:  Front Cell Infect Microbiol       Date:  2022-05-06       Impact factor: 6.073

2.  Resistance and Heteroresistance to Colistin in Escherichia coli Isolates from Wenzhou, China.

Authors:  Wenli Liao; Jie Lin; Huaiyu Jia; Cui Zhou; Ying Zhang; Yishuai Lin; Jianzhong Ye; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-10-09       Impact factor: 4.003

3.  Antimicrobial Resistance Profile of mcr-1 Positive Clinical Isolates of Escherichia coli in China From 2013 to 2016.

Authors:  Baiyuan Li; Bixia Ke; Xuanyu Zhao; Yunxue Guo; Weiquan Wang; Xiaoxue Wang; Honghui Zhu
Journal:  Front Microbiol       Date:  2018-10-23       Impact factor: 5.640

4.  Evaluation of resazurin-based assay for rapid detection of polymyxin-resistant gram-negative bacteria.

Authors:  Huaiyu Jia; Renchi Fang; Jie Lin; Xuebin Tian; Yajie Zhao; Lijiang Chen; Jianming Cao; Tieli Zhou
Journal:  BMC Microbiol       Date:  2020-01-08       Impact factor: 3.605

Review 5.  Worldwide Prevalence of mcr-mediated Colistin-Resistance Escherichia coli in Isolates of Clinical Samples, Healthy Humans, and Livestock-A Systematic Review and Meta-Analysis.

Authors:  Carlos Bastidas-Caldes; Jacobus H de Waard; María Soledad Salgado; María José Villacís; Marco Coral-Almeida; Yoshimasa Yamamoto; Manuel Calvopiña
Journal:  Pathogens       Date:  2022-06-08

6.  Complete genome sequences of two Escherichia coli clinical isolates from Egypt carrying mcr-1 on IncP and IncX4 plasmids.

Authors:  Ahmed M Soliman; Hazem Ramadan; Liansheng Yu; Junzo Hisatsune; Motoyuki Sugai; Shimaa S Elnahriry; Hirofumi Nariya; Ramadan A El-Domany; Toshi Shimamoto; Charlene R Jackson; Tadashi Shimamoto
Journal:  Front Microbiol       Date:  2022-09-09       Impact factor: 6.064
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.